FINOX Biotech has submitted the Marketing Authorisation Application (MAA) for its biosimilar recombinant Follicle Stimulating Hormone (r-FSH) BEMFOLA to the European Medicines Agency. The submission was based on a comprehensive clinical ...
Tags: FINOX Biotech, Marketing Authorisation Application, Medicines, healthcare
BS reported that 8 years ago, Ms Kada Majhi, a tribal woman of Kinari, a village in the Kalahandi district of Odisha eked out a living with paltry wages as a daily laborer. When Vedanta Aluminium started constructing a 1 million tonne per ...
Savient Pharmaceuticals's Krystexxa (pegloticase) has received positive opinion recommending approval of a marketing authorization from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) following ...
Tags: Savient Krystexxa, positive CHMP, EMA
At the LightShow East in Washington DC,Oct.3-4,Aleddra's 1-ft LED T8 sample tube quickly became one of the hottest giveaways.This sample T8 with Double Safety Switch(DSS)surprised tradeshow attendees with its intuitive safety design that ...
The Food and Drug Administration (FDA) has accepted Dynavax Technologies' heplisav biologics license application (BLA) for immunization against infection caused by all known subtypes of hepatitis B virus in adults 18 through 70 years of ...
US based Ariad Pharmaceuticals has submitted New Drug Application (NDA) for its investigational BCR-ABL inhibitor, ponatinib for the approval of US Food and Drug Administration (FDA). Ponatinib is indicated for patients with resistant or ...
Tags: BCR-ABL inhibitor, CML, Ph+ALL
Genzyme, a Sanofi company, has submitted a supplemental biologics license application (sBLA) to the FDA and marketing authorization application (MAA) to EMA for Lemtrada to treat relapsing multiple sclerosis (RMS). In collaboration with ...
Tags: sBLA, relapsing multiple sclerosis, RMS
Basilea Pharmaceutica has submitted a marketing authorization application (MAA) under the European decentralized procedure for its novel investigational antibiotic, ceftobiprole, to treat pneumonia in hospitals. The submission of the ...
European Medicines Agency (EMA) has accepted to review Pfizer's marketing authorization application (MAA) for bazedoxifene/conjugated estrogens (BZA/CE). BZA/CE is designed for postmenopausal women with a uterus for the treatment of ...
Tags: bazedoxifene conjugated estrogens, BZA/CE, estrogen deficiency symptoms
Zurich Insurance has reported a net income of $1.14bn for the first quarter of 2012, compared to $640m for the same period in 2011. Business operating profit for the first quarter of 2012 surged to $1.38bn, compared to $854m in the ...
Tags: Zurich Insurance, insurance industry, insurance market, net income
Astellas Pharma Europe, a European subsidiary of Astellas, has introduced Dificlir (generic name: fidaxomicin) tablets in the Europe. Dificlir, indicated to treat Clostridium difficile infections (CDI), is an orally administered, ...
Tags: Dificlir, fidaxomicin, CDI
Ferrer Internacional has decided to withdraw the marketing authorisation application (MAA) for Egrifta (tesamorelin) 2mg, powder for solution for injection in Europe. Ferrer formally notified the European Medicines Agency of its decision. ...
Tags: DME, healthcare products, pSivida
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended SkyePharma's flutiform (fluticasone propionate/formoterol fumarate) for European marketing approval. Flutiform is a ...
Tags: Skyepharma Flutiform, SkyePharma, long-acting beta-agonist
Aleddra LED Lighting,a business unit of Lightel Technologies,Inc.,today announced it starts to offer cost-effective product lines for Emerging Markets. aleddra LED Lighting,a leader in LED T8 retrofit market based in Seattle,expands its ...
Tags: Aleddra, Emerging Markets, LED Lighting, Seattle
The European Medicines Agency (EMA) has accepted to review the Dynavax Technologies Marketing Authorization Application (MAA) for Heplisav. Heplisav is indicated for immunization against infection caused by all known subtypes of hepatitis ...